Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and pharmacodynamics of three antithrombotics via two routes of administration
2007-000150-31Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Jul 2007
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of danaparoid sodium, fondaparinux and nadroparin in thromboembolism and venous thromboembolism (VTE) (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Time course of anti-Xa levels. Started Jul 2007; status: completed.
02
Drugs
danaparoid sodiumfondaparinuxnadroparin
03
Conditions
thromboembolismvenous thromboembolism (VTE)
Beyond the preview
Go deeper on 2007-000150-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000150-31.